Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy (Q34297893)

1 August 2017

1 reference

title

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy (English)

1 reference

1 August 2017

main subject

anti-retroviral agent

0 references

0 references

Burman WJ

1 reference

1 August 2017

Jones BE

series ordinal

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

164

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

7-12

1 reference

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Using therapeutic drug monitoring to dose the antimycobacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Paradoxical expansion of intracranial tuberculomas during chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2101133

10.1164/AJRCCM.164.1.2101133

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference